Zydus Lifesciences’ New Jersey facility clears USFDA inspection with nil observations

Zydus Lifesciences’ New Jersey office gets nil observations in USFDA inspection

Zydus Lifesciences said the USFDA completed an inspection of its New Jersey office with nil observations from September 22 to September 25, 2026.